| Sponsor | | | Type | StatusCT | | IBCSG | 25-02 | TEXT: Exemestane | Breast | Open | | SWOG | S0221 | Paclitaxel | Breast | Open | | SWOG | S0226 | Anastrozole, fulvestrant | Breast | Open | | SWOG | S0307 | Bisphosphonates Breast | Breast | Open | | SWOG | S0500 | Tx per Circulating Tumor Cells | Breast | Open | | SWOG | S0622 | Dasatinib | Breast | Open | | ECOG | PACCT-1 | TAILORx: Individualized Treatment | Breast | Open | | NSABP | B-41 | AC = T, Lapatinib, Trastuzumab | Breast | Open | | CALBG | C80405 | Bevacizumab, Cetuximab | GI- Colon | Open | | SWOG | S0353 | Gemcitabine | GI-Bladder | Open | | SWOG | S0337 | Gemcitabine | GI-Bladder | Open | | SWOG | S0421 | Docetaxel, Atrasentan | GI-Prostate | Open | | NCIC | PR.11 | START: Active Surveillance v. Radical Tx | GU-prostate | Open | | RTOG | R0415 | XRT | GU-prostate | Open | | RTOG | R0232 | XRT | GU-prostate | Open | | CALGB | C90202 | Zolendronic acid | GU-prostate | Open | | CALGB | C90203 | PUNCH: Neo-adjuvant + RP v. RP | GU-prostate | Open | | ECOG | E2805 | Adjuvant Sorafenib or Sunitinib | GU-renal | Open | | ECOG | E1302 | Docetaxel v. Docetaxel + Iressa | Head & Neck | Open | | SWOG | S0515 | CHOP, Rituximab, Bevacizumab | Heme-Lymphoma | Open | | SWOG | S8819 | Spec. Repository | Heme-Lymphoma | Open | | SWOG | S8947 | Spec. Repository | Heme-Lymphoma | Open | | SWOG | S9007 | Cytogenetics | Heme-Lymphoma | Open | | SWOG | S9910 | Spec. Repository | Heme-Lymphoma | Open | | SWOG | S0424 | Molecular Epidemiology Case-Series Study | Lung-NSCLC | Open | | SWOG | S0429 | Cetuximab, Docetaxel, Radiation Therapy | Lung-NSCLC | Open | | SWOG | S0526 | Pemetrexed | Lung- BAC | Open | | SWOG | S0533 | Bevacizumab, Cisplatin, Docetaxel,Etoposide, RT | Lung-NSCLC | Open | | SWOG | E1505 | Vinorelbine, Cisplat, Docetaxel, Gemcitabine, Bevacizum | Lung-NSCLC | Open | | SWOG | S9808 | Long-term follow-up | Other | Open |
SWOG = Southwest Oncology Group
CTSU = Cancer Trials Support Unit
CALGB = Cancer and Acute Leukemia Group B
ECOG = Eastern Cooperative Oncology Group
NSABP = National Surgical Adjuvant Breast and Bowel Project
Click here to go back to the Main Clinical Trials Page
Clinical Trial List
|
Brachytherapy and IMRT
